Skip to main content

O-Yeong Lee

Hanyang University · 医学

研究室紹介

Professor O-Yeong Lee's research lab specializes in gastrointestinal motility disorders, with a strong focus on irritable bowel syndrome (IBS) and functional gastrointestinal diseases in Asian populations. The lab investigates the pathophysiological mechanisms underlying IBS, including visceral hypersensitivity, altered gut transit, and the role of psychosocial factors, while also evaluating novel therapeutic interventions such as tegaserod and DA-9601 for symptom management. A key emphasis is placed on understanding ethnic and regional differences in GI physiology and disease presentation, particularly in the Asia-Pacific region.

irritable bowel syndromevisceral hypersensitivitygastrointestinal motilityfunctional dyspepsiaethnic differences in GI disease

Research Overview

Papers
101
Total Citations
1,111
Papers (5y)
10
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
10total
2017
2022
2023
2024
2025
Citations per year (5y)
199total
20172022202320242025

Selected Papers

15
1
Article|231 citations·2003
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
John Kellow, O. Y. Lee, F. Y. Chang, Satawat Thongsawat, M Z Mazlam, Hok Pan Yuen, Kok‐Ann Gwee, Young‐Tae Bak, J. A. Jones, Amy W. Wagner
SJR Q1GutOA

BACKGROUND: Tegaserod has been shown to be an effective therapy for the multiple symptoms of irritable bowel syndrome (IBS) in Western populations. However, little information is available regarding the use of tegaserod in the Asia-Pacific population. AIMS: To evaluate the efficacy, safety, and tolerability of tegaserod versus placebo in patients with IBS from the Asia-Pacific region. PATIENTS: A total of 520 patients from the Asia-Pacific region with IBS, excluding those with diarrhoea predomin

GastroenterologyMedicine
2
Article|190 citations·2001
Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome
Lin Chang, O. Y. Lee, Bruce Naliboff, Max J. Schmulson, Emeran Mayer
SJR Q1The American Journal of Gastroenterology

Bloating and visible abdominal distension may arise from two distinct but interrelated physiological processes. Although the sensation of bloating may be related to enhanced sensitivity to visceral afferent stimulation, abdominal distension in more severely affected patients may be related to triggering of a visceromotor reflex affecting the tone of abdominal wall muscles.

GastroenterologyMedicine
3
Review|170 citations·2017
Colonic immune cells in irritable bowel syndrome: A systematic review and meta‐analysis
Mohammad Bashashati, Shirin Moossavi, Cesare Cremon, Maria Raffaella Barbaro, Sharareh Moraveji, Geoffrey A. Talmon, Nima Rezaei, Patrick A. Hughes, Zhaoxiang Bian, Chang Hwan Choi, O. Y. Lee, Moı̈se Coëffier
SJR Q1Neurogastroenterology & Motility

Abstract Background & Aims Increases in mucosal immune cells have frequently been observed in irritable bowel syndrome (IBS) patients. However, this finding is not completely consistent between studies, possibly due to a combination of methodological variability, population differences and small sample sizes. We performed a meta‐analysis of case – control studies that compared immune cell counts in colonic biopsies of IBS patients and controls. Methods PubMed and Embase were searched in Febr

GastroenterologyMedicine
4
Article|70 citations·2011
Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine
K. J. Lee, N. Y. Kim, Jaibum Kwon, Kyu Chan Huh, O. Y. Lee, J. S. Lee, Suck Chei Choi, Chong Il Sohn, Seung‐Jae Myung, Hyojin Park, MIN‐SEOK CHOI, Young‐Tae Bak
SJR Q1Neurogastroenterology & MotilityOA

BACKGROUND: The 5-HT(3) receptor antagonists are known to be effective for the treatment of diarrhea-predominant irritable bowel syndrome (IBS), but not widely used yet. The aim of this study was to compare the efficacy and safety of ramosetron, a 5-HT(3) receptor antagonist, and mebeverine in male patients with IBS with diarrhea (IBS-D). METHODS: This study was performed in a multicenter, randomized, open-label design. Data of 343 male patients with IBS-D who were randomized to either a 4-week

GastroenterologyMedicine
5
Article|50 citations·2004
한국인에서 EQ-5D를 이용한 건강 관련 삶의 질 측정
성상석, 최찬범, 성윤경, 박용욱, 이혜순, 엄완식, 김태환, 전재범, 유대현, 이오영, 배상철

Objective: There has been no data on health related quality of life (HRQOL) in general Korean population. Assessing factors affecting HRQOL in Koreans is fundamental in HRQOL research. The objective of this study is to assess HRQOL in Korean using Korean version of EQ-5D (KEQ-5D). Methods: HRQOL was assessed using KEQ-5D from 1,044 randomly selected population representing general Korean population with telephone interview Result: The mean KEQ-5D utility score in Korean was 0.88 (range: -0.59~

6
Article|46 citations·2015
Efficacy of combination therapy with probiotics and mosapride in patients withIBSwithout diarrhea: a randomized, double‐blind, placebo‐controlled, multicenter, phase II trial
Chang Hwan Choi, Joong Goo Kwon, SeonWook Kim, Seung‐Jae Myung, K. S. Park, Chong Il Sohn, Poong‐Lyul Rhee, K. J. Lee, O. Y. Lee, Ha‐Kyun Jung, Sam Ryong Jee, Y.T. Jeen
SJR Q1Neurogastroenterology & MotilityOA

BACKGROUND: Probiotics can be beneficial in irritable bowel syndrome (IBS). Mosapride citrate, a selective 5-HT4 receptor agonist, stimulates gastrointestinal motility. We investigated the efficacy of combination therapy with probiotics and mosapride for non-diarrheal-type IBS. METHODS: Two hundred and eighty-five IBS patients were randomly assigned to either a combination of probiotics (Bacillus subtilis and Streptococcus faecium) and mosapride at one of four different doses or a placebo for 4

GastroenterologyMedicine
7
Article|29 citations·2004
한국인 만성 질환과 건강 관련 삶의 질
윤재희, 강종명, 김경수, 김승현, 김태환, 박용욱, 성윤경, 손주현, 송병주, 엄완식, 윤호주, 이오영

Objective: Few studies have examined the impact of chronic diseases on populations using a comprehensive health-related quality of life (HRQOL) in Korea. We assessed HRQOL of patients with 16 common chronic diseases. Methods: We interviewed patients with chronic diseases (n=980) and healthy control (n=288) using two HRQOL measurements: Korean Medical Outcome Study Short Form-36 (KSF-36) and Korena EuroQol-5 Dimensions (KEQ-5D), and questions on sociodemographic and clinical characteristics. R

8
Article|26 citations·2012
Carbohydrate but not fat is associated with elevated aminotransferases
Oh‐Sung Kwon, Dae Won Jun, Seolha Lee, Kang Nyeong Lee, H. L. Lee, O. Y. Lee, Byung Chul Yoon, Ho Soon Choi
SJR Q1Alimentary Pharmacology & Therapeutics

BACKGROUND: Recently, many studies reported that high carbohydrate and simple sugar intake increase a risk of obesity and metabolic syndrome significantly. AIM: To investigate the effect of carbohydrate on aminotransferase levels in Korea, where the proportion of carbohydrate in meals is extremely high but fat is low. METHODS: We used the data of Korean National Health and Nutrition Examination Surveys (KNHANES). A total of 19 749 people were included. Amounts and types of consumed foods were ex

PhysiologyMedicine
9
Article|26 citations·2012
Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open‐label, non‐inferiority, randomized controlled study
Won Sohn, O. Y. Lee, J. G. Kwon, K. S. Park, Yun Jeong Lim, T. H. Kim, Susie Jung, J. I. Kim
SJR Q1Neurogastroenterology & Motility

BACKGROUND: Tricyclic antidepressants have good efficacy in irritable bowel syndrome with diarrhea (IBS-D), but their clinical use is limited by considerations of tolerability. Tianeptine, another antidepressant, acts as a selective serotonin reuptake enhancer. We compared tianeptine with amitriptyline for the treatment of patients with IBS-D. METHODS: We undertook a multicenter, randomized, open-label, non-inferiority clinical study that compared tianeptine with amitriptyline, each in combinati

GastroenterologyMedicine
10
Article|21 citations·2013
Association between Symptoms of Irritable Bowel Syndrome and Methane and Hydrogen on Lactulose Breath Test
이강녕, 고동희, 이오영, 손원, 이상표, 전대원, 이항락, 윤병철, 최호순, 함준수
Journal of Korean Medical Science

Whether hydrogen and methane gas produced during lactulose breath test (LBT) are associated with symptoms of irritable bowel syndrome (IBS) is not determined. We aimed to investigate whether hydrogen and methane on LBT are associated with IBS symptoms. Sixty-eight IBS patients meeting the Rome III criteria for IBS, and 55 healthy controls,underwent LBT. The IBS subjects recorded their customary gastrointestinal symptoms on a questionnaire using visual analogue scales. LBT positivity was defined

11
Article|18 citations·2011
Prevention of NSAID-Associated Gastroduodenal Injury in Healthy Volunteers-A Randomized, Double-Blind, Multicenter Study Comparing DA-9601 with Misoprostol
이강녕, 이오영, 최명규, 최석렬, 이동호, 이용찬, 김태년, 최석채, 류종선, 설상영
Journal of Korean Medical Science

In addition to inhibiting cyclooxygenase and prostaglandin, nonsteroidal anti-inflammatory drugs (NSAIDs) may cause gastroduodenal injuries due to reactive oxygen species produced by recruited inflammatory cells. DA-9601 is a novel antioxidant with anti-inflammatory and cyto-protective effects. This study was conducted to compare the efficacy and safety of DA-9601 with misoprostol for preventing NSAID-associated gastroduodenal injury. In this randomized, double-blind, multicenter, noninferiority

12
Article|14 citations·2006
위식도역류질환 환자의 식이 위험요인 및 삶의 질
양선영, 이오영, 김혜은, 장유경, 윤병철, 최호순, 정용건, 조찬호

목적 : 우리나라 위식도 역류질환자들의 식습관 실태를 파악하고 질환의 위험 요인으로 생각되는 식품에 대한 섭취 기호도 및 식이습관을 조사하여 질환 정도와의 관련성을 파악하며 건강과 관련된 신체적, 정서적 삶의 질을 평가하였다.

13
Article|14 citations·2024
Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi‐Center, Randomized, Double‐Blind, Active‐Comparator Phase 4 Trial
Cheol Min Shin, Suck Chei Choi, Jin–Woong Cho, Seung Young Kim, Ok‐Jae Lee, Do Hoon Kim, Yu Kyung Cho, Ju Yup Lee, Sang Kil Lee, Jeong Eun Shin, Gwang Ha Kim, Seon‐Young Park
SJR Q1Neurogastroenterology & MotilityOA

BACKGROUND: The aims of this study were to confirm the non-inferiority of tegoprazan to lansoprazole up to week 4 in patients with erosive esophagitis (EE) and to evaluate its effectiveness in rapid mucosal healing and symptom relief at week 2. METHODS: In this multi-center, randomized, double-blind, active-comparator non-inferiority trial, 218 patients with endoscopically confirmed EE (Los Angeles Classification Grades A-D) were randomly allocated to either the tegoprazan (50 mg) or lansoprazol

GastroenterologyMedicine
14
Article|13 citations·2011
Correlation between Complicated Diverticulitis and Visceral Fat
정종헌, 이항락, 김진옥, 태혜진, 정석현, 이강녕, 전대원, 이오영, 윤병철, 최호순, 함준수, 송순영
Journal of Korean Medical Science

The aim of this study was to examine the relationship of complications related to diverticulitis and visceral obesity. The study was based on a retrospective case note review conducted at the Hanyang University Hospital. Patients were diagnosed with diverticulitis based on clinical symptoms and abdominal computed tomography (CT) findings and divided into two groups: those admitted with complicated diverticulitis and those with a simple diverticulitis episode. We compared the body mass index (BMI

15
Review|12 citations·1999
Common functional gastrointestinal disorders: Nonulcer dyspepsia and irritable bowel syndrome
O. Y. Lee, Max Schmulson, Emeran A. Mayer
Clinical cornerstone
GastroenterologyMedicine

Research Areas

GastroenterologyPhysiology

O-Yeong Leeの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。